The evolving landscape of chronic lymphocytic leukemia on diagnosis, prognosis and treatment

Claudia Pérez-Carretero, Isabel González-Gascón-y-marín, Ana E. Rodríguez-Vicente, Miguel Quijada-álamo, José Ángel Hernández-Rivas, María Hernández-Sánchez, Jesús María Hernández-Rivas

Research output: Contribution to journalReview articlepeer-review

14 Scopus citations

Abstract

The knowledge of chronic lymphocytic leukemia (CLL) has progressively deepened during the last forty years. Research activities and clinical studies have been remarkably fruitful in novel findings elucidating multiple aspects of the pathogenesis of the disease, improving CLL diagnosis, prognosis and treatment. Whereas the diagnostic criteria for CLL have not substantially changed over time, prognostication has experienced an expansion with the identification of new biological and genetic biomarkers. Thanks to next-generation sequencing (NGS), an unprecedented number of gene mutations were identified with potential prognostic and predictive value in the 2010s, although significant work on their validation is still required before they can be used in a routine clinical setting. In terms of treatment, there has been an impressive explosion of new approaches based on targeted therapies for CLL patients during the last decade. In this current chemotherapy-free era, BCR and BCL2 inhibitors have changed the management of CLL patients and clearly improved their prognosis and quality of life. In this review, we provide an overview of these novel advances, as well as point out questions that should be further addressed to continue improving the outcomes of patients.

Original languageEnglish
Article number853
JournalDiagnostics
Volume11
Issue number5
DOIs
StatePublished - 2021
Externally publishedYes

Keywords

  • Chronic lymphocytic leukemia (CLL)
  • Diagnosis
  • Evolution
  • Prognosis
  • State-of-the-art
  • Treatment

Fingerprint

Dive into the research topics of 'The evolving landscape of chronic lymphocytic leukemia on diagnosis, prognosis and treatment'. Together they form a unique fingerprint.

Cite this